Get 40% Off
🔥 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool.See stock ideas

Essentra: Doing It Better

Published 02/21/2017, 06:54 AM
Updated 07/09/2023, 06:31 AM
ESNT
-

Essentra PLC (LON:ESNT): A new CEO-led corporate recovery programme is underway and many key ingredients to achieve this are visible. Acknowledging lower FY17e earnings, clearer strategic direction and turnaround indicators should be more tangible from H2. We expect positive newsflow to gather momentum.

Earnings under pressure, dividend maintained

FY16 saw lower reported profit and margins in all three divisions, despite FX tailwinds. Group operating profit came in at £131.9m, in line with the 23 January update (and below November guidance of £137-142m). The trading result was largely attributable to internal inefficiencies, while underlying markets were largely satisfactory. While there were some signs of performance improving in H2, Health & Personal Care Packaging (HPC) was still deteriorating at the year-end (and so far into FY17). An HPC business unit review resulted in a c £124m intangible impairment charge (c 26% of end FY15 carrying values, 40%+ of net Clondalkin consideration). More positively, DPS was maintained at FY15 levels (covered 1.4x); cover will narrow further in FY17, but our sense is that it can be held again.

Calm balance sheet to facilitate new strategy

Year-end net debt of £379m will fall to a pro forma c £170m (gross c £230m) after the Porous Technologies disposal in Q117, which is c 1.4x continuing EBITDA. This leaves plenty of headroom within a £270m and €168m RCF (to 2019). It is early days strategically, but initial signs are that major surgery is not expected; each division is considered to have market presence and the potential to reach previous peak margins (group ROS 17%+). H117 results (28 July) will give a fuller strategy update, but one marker is for business stability (in group, operational and financial processes) to be achieved in 12 months. Exceptional cash costs (eg corporate reorganisation, footprint changes, consultancy fees) are impossible to quantify at this stage; we consider that c £10m pa for a couple of years could be comfortably accommodated (although cash dividend cover needs to be monitored). We estimate that this would maintain net debt around the indicated pro forma level.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

To read the entire report Please click on the pdf File Below

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.